Email address
[email protected]Contact number
+33 1 4062 2000Chambers Review
Latham & Watkins has a top private equity practice with a focus on high-end transactions at both national and international levels, with particular prowess in LBO transactions. The law firm leverages an extensive network of offices across Europe, Asia and the USA to assist with multi-jurisdictional issues. The lawyers provide full-service advice and expertise, representing all types of clients, including investment funds, asset management companies and private equity houses. The team acts across the pharmaceutical, healthcare, technology, and food and drink sectors.
Work Highlights
- Latham & Watkins advised Ardian on the EUR1.2 billion sale of Unither Pharmaceuticals to a consortium comprising of GIC, IK Partners, Keensight and Parquest.
Strengths
Provided by Chambers
"They are very good locally with a good team in Paris. The lawyers are close to the client, able to adapt and give tailor-made advice, and at the same time they have the strength of an international firm. I am very impressed with them."
"They are very good locally with a good team in Paris. The lawyers are close to the client, able to adapt and give tailor-made advice, and at the same time they have the strength of an international firm. I am very impressed with them."
Notable Practitioners
Thomas Forschbach is a standout adviser on large-scale disposals and acquisitions and is regularly called upon by key private equity houses. He is well placed to handle both domestic and international mandates.
Gaëtan Gianasso undertakes strategic LBO transactions on behalf of French and international private equity firms. He is well prepared to advise on multi-jurisdictional cases.
Denis Criton represents international investment firms, including asset managers, in large-scale LBO transactions.
"Denis Criton was knowledgeable and managed to get the end result we wanted. He was heavily involved and had a great deal of oversight."
Olivier du Mottay acts for domestic and international private equity funds on majority-stake acquisitions and disposals.
"He is a deal-maker."